The nomination committee of biotech firm Bio-Works has proposed the election of Eva Lindskog and Andrea Ballagi to the Board of Directors ahead of this spring's Annual General Meeting.

The committee also recommends the re-election of the current board members, with Peter Ehrenheim continuing as Chairman.

Lindskog currently serves as Chief Commercial Officer at NanoTemper Technologies and brings extensive experience from the life sciences industry.

Ballagi also boasts a long career in the sector and currently holds global responsibility for oncology market development at Olink Proteomics, a company now part of the industry giant Thermo Fisher Scientific.